Hot Investor Mandate 15: Established Foundation Provides Multiple Grant Programs to Support Early-Stage Companies in Alzheimer’s Disease and Dementia

4 Jan

A USA-based foundation that was established in 1998 is currently funding new investment opportunities in the life science space (specifically Alzheimer’s disease and related dementia) through two grants; the first program is for existing early stage private companies, and the second program supports the establishment of new companies. The foundation typically provides funding of up to $350,000 per year for up to two years for pre-clinical programs or $1-3 M for clinical stage programs. The foundation will invest with other groups for larger deals. The foundation typically provides investments as equity, a convertible loan, and recoverable grants, and will consider investments globally.

The foundation is currently most interested in companies in the therapeutics space but will consider diagnostics, if the technology provides significant benefit for Alzheimer’s patients or will accelerate clinical trials. The firm is interested in both small molecules and biologics and will providing funding from companies anywhere from high throughput screening to Phase IIa of Clinical Trials.

The foundation is looking for companies with experienced management teams. The foundation looks to be an active value-added investor to help companies with securing future financing rounds when appropriate.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: